Health Care Expenditures and Cost Drivers in Canada

Similar documents
The Sustainability of Canadian Provincial Government Health Spending: An Expenditure Category Approach

Meeting the Care Needs of Canada s Aging Population.

CANM-CAMRT JOINT ANNUAL CONFERENCE MARCH 22-24, 2018 VANCOUVER, B.C.

Is There a Roemer s Law for Physicians? Physician Numbers As a Driver of Provincial Government Health Spending

June Decentralization, Provincial Tax Autonomy and Equalization in Canada

An overview of recent macroeconomic developments in Canada

LABOUR FORCE STATISTICS REPORT MAY 2018

LABOUR FORCE STATISTICS REPORT APRIL 2018

LABOUR FORCE STATISTICS REPORT OCTOBER 2018

LABOUR FORCE STATISTICS REPORT AUGUST 2018

Provincial Government Health Spending and Value for Money: An Overview of Canadian Trends,

April An Analysis of Saskatchewan s Productivity, : Capital Intensity Growth Drives Strong Labour Productivity Performance CENTRE FOR

The Current and Future Contribution of the Aboriginal Community to the Economy of Saskatchewan

Physician Services Analysis

The National Physician Database: Data and Reports 2006 National Meeting on Physician Compensation Vancouver, British Columbia, Canada

Fiscal Federalism in Canada

Selected Demographic and Economic Characteristics of the Aboriginal Population in Saskatchewan

Budget Paper B FINANCIAL REVIEW AND STATISTICS

April 2011 CENTRE FOR LIVING STANDARDS. CSLS Research Report i. Christopher Ross THE STUDY OF

Early, But Fundamentally Correct

Unless otherwise indicated, this product uses data provided by Canada s provinces and territories.

April An Analysis of Prince Edward Island s Productivity, : Falling Multifactor Productivity Dampens Labour Productivity Growth

April An Analysis of Nova Scotia s Productivity Performance, : Strong Growth, Low Levels CENTRE FOR LIVING STANDARDS

January 12, Minimum Wage Review Committee Report

TAX FACTS What s Inside. Quick Estimates. RRSP, RPP and DPSP Limits. Top Personal Rates for CPP, EI and QPIP Rates

ALBERTA FORECAST HOW LONG WILL IT LAST?

THE QUÉBEC ECONOMIC PLAN NOVEMBER 2017 UPDATE TABLES AND CHARTS

Tobacco tax policy in Ontario

ISBN Legal deposit Bibliothèque nationale du Québec, Publication date: October Web site:

DELIVERING DIVIDENDS OF A STRONG ECONOMY

TAXING QUESTIONS ABOUT PROPERTY TAXATION

151 Slater Street, Suite 710 Ottawa, Ontario K1P 5H , Fax September, 2012

CHAPTER 4: GROWTH, UNEMPLOYMENT, AND INFLATION

The Oil Shock: How Shocking Is It? By Avery Shenfeld, Chief Economist & Managing Director

The Budgetary Process Supporting the Pre-election Report

December 8, Minimum Wage Review Committee Report

Québec s Economy and Public Finances

ECON 361: Income Distributions and Problems of Inequality

SEPTEMBER 2017 UPDATE

Provincial Debt Summary

Strong Fiscal Management Pays Dividends

Provincial Pre-Budget Submission

Some provinces now face the downside of tight labour markets

The Rise of Western Canada: Focus Alberta

Canada In a Messy World By Avery Shenfeld, Chief Economist & Managing Director

North American Economic Outlook: Will the Recovery Be Sustained? U.S. Economic Outlook:

HOUSING MARKET OUTLOOK Canada Edition

Semi-annual Return of Capital Payments. Alternative to investing in bond ETFs, mutual funds or holding the Underlying Bonds.

Usage of Sickness Benefits

THE QUÉBEC ECONOMIC PLAN. March The Generations Fund BUDGET Québec Is Repaying Its Debt

Summary Public School Indicators for the Provinces and Territories, to

Discussion paper. Personal. Income. Tax Reduction. Gouvernement du Québec Ministère des Finances

Comparing Ontario s Fiscal Position with Other Provinces

Comparing Alberta s Economic and Fiscal Performance with Other North American Energy Jurisdictions

Jobs for Today and Tomorrow

CONSUMER PRICE INDEX REPORT NOVEMBER 2017

North American Economic Outlook: Gradual Though Sustained Recovery

February 22, Minimum Wage Review Committee Report

Alberta back in the saddle: to lead all provinces in growth in 2017

The Newfoundland and Labrador Economy: A Reality Check

COMMON DETERMINANTS AND COST- DRIVERS OF PROVINCIAL GOVERNMENT HEALTH EXPENDITURES

Fair Drug Prices for Nova Scotians

CONSUMER PRICE INDEX REPORT OCTOBER 2017

IMBA CONFERENCE April 2011

Canadian Fiscal Federalism and the Dual VAT

ALBERTA PROFILE: YOUTH

Budget Paper B SUPPLEMENTARY FINANCIAL INFORMATION

Understanding Drug Formulary Listing Decisions in Canada: a Logistic Model. Charles Thompson Candidate, MSc. University of Ottawa

When and How Much. Robert Clark Natural Resources Canada

Model of Long-Term Health Care Cost Trends in Canada

Budget Paper D TAXATION ADJUSTMENTS

Value of Consumer Health Products The Impact of Switching Prescription Medications to Over-the-Counter

Our FISCAL Future. Starting the Conversation

Recent Trends in Saskatchewan s Labour Market: Implications for PSE

2014 Report of the Auditor General of New Brunswick Volume I & II

January 27, Minimum Wage Review Committee Report

The Implications of New Brunswick s Population and Labour Market Forecasts

Releases. New products and studies 8

How to Fix The Canadian Recession

2015 INSOLVENCY AND RESTRUCTURING FORUMS. Retail insolvency. A practitioner s guide to key issues and challenges

The Slave Geologic Province

Governance of WorkSafeNB

Federal Financial Support to Provinces and Territories: A Long-term Scenario Analysis

Consultations. Board s Excessive Price Guidelines

ONTARIO HEALTH SECTOR. An Updated Assessment of Ontario Health Spending

Why Alberta Needs a Sales Tax

Turning Japanese? May 2016

Pharmacy Markups. Key Themes from the Interviews. Louis Thériault Vice-President, Industry Strategy and Public Policy The Conference Board of Canada

BC ECONOMIC BACK DROP AND DEMOGRAPHICS

ECONOMIC STUDIES I JUNE 7, Looking Ahead Together Conference Mistissini, Quebec. Economic outlook. Jimmy Jean, Senior Economist Desjardins Group

A prescription for savings:

What s Next for Canada s Construction Industry,

Edmonton Real Estate Forum. Ron Gilbertson President and CEO Edmonton Economic Development Corporation

The R Word. Benjamin Tal Senior Economist. April 2008 Economics & Strategy

LABOUR MARKET TRENDS IN SASKATCHEWAN

Securing the Future A 10-Year Sustainability Plan for Newfoundland and Labrador

CCHS and NPHS An improved Health Survey Program at Statistics Canada

Budget Paper D FISCAL ARRANGEMENTS

Submission to the Independent Tax Review Committee, Newfoundland and Labrador

North American Economic Outlook: Climbing Out of Recession

Transcription:

Health Care Expenditures and Cost Drivers in Canada Focus on Pharmaceuticals Louis Thériault, Vice-President Industry Strategy and Public Policy The Conference Board of Canada April 26, 2017 conferenceboard.ca

Context Canada is a rich country and as expected spends a lot on health care By comparison, Canada spends even more than other rich OECD countries; who pays for it contrasts significantly Good news: there is a lot of money in the system that can be redeployed Low health care spending growth is temporary, robust growth will resume Aging population Home and Community Care Precision medicine and high cost drugs Slower GDP growth will constrain fiscal capacity Innovation will be the central theme business models, procurement, pharmaceuticals, medical devices, technology, etc. 2

Health Spending per Capita among Highest 2015 or nearest year, US $, PPP Source: OECD Statistics 3

Slower Growth in Health Expenditures per cent of GDP, Canada $199B in 2011 $228B in 2016 4

Health Spending Correlated with Fiscal Reality Federal and Regional Deficits, National Accounts Basis, $billions 20 Federal Provinces 10 0-10 -20-30 -40-50 Sources: Statistics Canada; The Conference Board of Canada. 5

Cost driver shares of average annual growth in public-sector health spending 6

Canada Among Highest Spenders on Pharmaceuticals retail spending on pharmaceuticals, per capita 7

Private Payer Share Much Larger in Canada retail spending on pharmaceuticals by type of financing, 2013 or nearest year 8

In 2015 Individuals for whom public drug programs paid $10,000 or more toward drug costs accounted for 2.1% of beneficiaries and 33.5% of public drug spending. Spending on statins decreased by 20.9% in 2012 but decreased by only 1.9% in 2015. Drug program spending per beneficiary for statins has decreased by 56.7%, from $304 in 2011 to $132 in 2015. Source: Prescribed Drug Spending in Canada: A Focus on Public Drug Programs, CIHI, 2016. 9

Population distribution by age, 2016 and 2035 600,000 2016 2035 500,000 400,000 300,000 200,000 100,000 0 Sources: The Conference Board of Canada; Statistics Canada. 10

Labour Force Growth average annual compound growth, per cent 2.0 1.5 1.0 0.5 0.0 1981-90 1991-00 2001-05 2006-15 2016-20f 2021-30f 2031-35f Sources: Statistics Canada; The Conference Board of Canada. 11

Contributions to Growth in Health Care Spending (average annual compound growth rate, forecast 2015-2030) Total Health Care Spending 5.6 Contributions: Changes in access 1.0 Demographic changes 1.8 Population growth 0.8 Aging 1.0 Inflation 2.9 NOTE: Numbers may not add due to rounding Source: The Conference Board of Canada. 12

Federal Fiscal Stimulus at the Cost of Deficits Federal government balance, public accounts basis, $ billions 20 10 0-10 -20-30 -40-50 -60 Source: Department of Finance. 13

Federal and Provincial Gov t Balances as a share of GDP, 2016-17 1.0 0.0-1.0-2.0-3.0-4.0-5.0-6.0 N.L. P.E.I. N.S. N.B. Que. Ont. Man. Sask. Alta. B.C. Federal Sources: The Conference Board of Canada; Statistics Canada; various government budgets. 14

Federal and Provincial Gov t Net Debt as a share of GDP, 2016-17 50% 40% 30% 20% 10% 0% N.L. P.E.I. N.S. N.B. Que. Ont. Man. Sask. Alta. B.C. Federal Sources: The Conference Board of Canada; Statistics Canada; various government budgets. 15

Challenges in Public Sector Spending (2011-2026 annual growth, difference) Source: The Conference Board of Canada.. 16

Challenges in Human Resources (2011-2026 annual growth, difference) Source: The Conference Board of Canada.. 17

Implications Governments make choices consistent with their capacity to pay Going forward, status quo will be challenged Pressure from an aging population offers an opportunity to re-examine how we deliver health care, what is included, and who pays The end of the patent cliff and emergence of high cost specialty treatments will increase growth in pharmaceutical costs Innovation in pharmaceuticals drugs and devices will offer unprecedented health benefits New business model needed to make sure Canadians have access to the right treatment for the right public health benefit at the right cost Scenario planning needed to quantify and inform the impact of policies, programs, and investments, as well as guide decision-making 18

conferenceboard.ca